Guidance for Infinity Pharmaceuticals (INFI)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| Q2 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2018 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q3 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q2 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2016 | N/A | N/A | $225.00M – 245.00M | $215.00M |  Raised |
Details |
| 2015 | N/A | N/A | $100.00M – 120.00M | $126.95M | = Maintained | Details |
| 2012 | ($1.30) – ($1.70) | ($1.46) | N/A | N/A | = Maintained | Details |
| 2012 | N/A | N/A | $47.10M | $61.70M | = Maintained | Details |
| 2011 | N/A | N/A | N/A | N/A | = Maintained | Details |
| 2011 | ($1.50) – ($1.13) | ($1.55) | $90.00M – 95.00M | $82.95M | = Maintained | Details |
